For the MMS-90 and MMS-180 trial arms, pregnant women with mild or moderate anemia (Hb 7.9– < 11.0 g/dL) will be referred to their midwife or doctor for guidance on the care and/or treatment of anemia during pregnancy. This evidence concerns the gene GSTM1 and anemia.